Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Adeptus Health Inc ADPTQ

Healthcare Medical Care
"Adeptus Health Inc owns and operates First Choice Emergency Rooms, the network of independent freestanding emergency rooms in the United States."

Recent & Breaking News (GREY:ADPTQ)

Adaptive Biotechnologies and Collaborators to Present Data from More Than 35 Abstracts at ASH 2020 Highlighting Clinical Relevance of MRD Testing with the clonoSEQ® Assay in Blood Cancer Patients

GlobeNewswire November 23, 2020

Preliminary Data from Real-World Study Demonstrate T-cell Testing Outperforms Antibody Testing in Identifying Past SARS-CoV-2 Infections

GlobeNewswire November 13, 2020

Adaptive Biotechnologies Announces Collaboration with GSK to Measure Minimal Residual Disease with clonoSEQ® Assay Across its Hematology and Oncology Portfolio

GlobeNewswire November 10, 2020

Adaptive Biotechnologies Reports Third Quarter 2020 Financial Results

GlobeNewswire November 10, 2020

Adaptive Biotechnologies to Report Third Quarter Financial Results on November 10, 2020

GlobeNewswire October 13, 2020

Adaptive Biotechnologies to Present at the Morgan Stanley 2020 Healthcare Conference

GlobeNewswire September 1, 2020

Adaptive Biotechnologies Reports Second Quarter 2020 Financial Results

GlobeNewswire August 10, 2020

Adaptive Biotechnologies to Present at the UBS Genomics 2.0 and Medtech Innovations Summit

GlobeNewswire August 10, 2020

Adaptive Biotechnologies Receives Expanded FDA Clearance for the clonoSEQ® Assay to Assess Minimal Residual Disease (MRD) in Patients with Chronic Lymphocytic Leukemia

GlobeNewswire August 6, 2020

Adaptive Biotechnologies Launches immunoSEQ T-MAP COVID, First Molecular T Cell Monitoring Tool for SARS-CoV-2

GlobeNewswire August 4, 2020

Adaptive Biotechnologies Launches National Clinical Trial to Develop Novel T-Cell Based Diagnostic for Lyme Disease

GlobeNewswire July 28, 2020

Adaptive Biotechnologies Announces Pricing of Public Offering of Common Stock

GlobeNewswire July 15, 2020

Adaptive Biotechnologies Announces Proposed Public Offering of Common Stock

GlobeNewswire July 14, 2020

Adaptive Biotechnologies to Report Second Quarter Financial Results on August 10, 2020

GlobeNewswire July 9, 2020

Adaptive Biotechnologies and Microsoft launch groundbreaking ImmuneCODE database to share populationwide immune response to the COVID-19 virus

PR Newswire June 11, 2020

UPDATE - Adaptive Biotechnologies to Participate in Upcoming June Investor Conferences

GlobeNewswire June 8, 2020

Adaptive Biotechnologies to Participate in Upcoming June Investor Conferences

GlobeNewswire May 27, 2020

Adaptive Biotechnologies Reports First Quarter 2020 Financial Results

GlobeNewswire May 12, 2020

Adaptive Biotechnologies to Present at the BofA Securities 2020 Healthcare Conference

GlobeNewswire May 6, 2020

Adaptive Biotechnologies and Microsoft launch virtual ImmuneRACE study to inform novel COVID-19 diagnostics to address unmet needs in testing

PR Newswire May 5, 2020